Anti-asthma drugs;Médicaments antiasthmatiques

Revue du Praticien

Volumn 51, Issue 5, 2001, Pages 523-531

  Devillier, P ^a  

^a HÔPITAL MAISON BLANCHE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOPHYLLINE; ANTIASTHMATIC AGENT; ANTIINFLAMMATORY AGENT; ASMASAL; BAMBUTEROL; BAMIFYLLINE; BECLOMETASONE; BECLOMETASONE DIPROPIONATE; BECLONE; BEMEDREX; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; BUDESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FENOTEROL; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL; FORMOTEROL FUMARATE; IPRATROPIUM BROMIDE; IPRATROPIUM BROMIDE PLUS SALBUTAMOL SULFATE; KETOTIFEN; KETOTIFEN FUMARATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHYLXANTHINE; MONTELUKAST; NEDOCROMIL; NEDOCROMIL SODIUM; OXEOL; OXITROPIUM BROMIDE; PIRBUTEROL; PIRBUTEROL ACETATE; PROLAIR; SALBUTAMOL; SALBUTAMOL SULFATE; SALMETEROL; SALMETEROL XINAFOATE; SPIR; SPREOR; TEDRALAN; TERBUTALINE; THEOPHYLLINE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; BRONCHODILATATION; DRUG MECHANISM; EXERCISE INDUCED ASTHMA; HUMAN; NEBULIZATION; REVIEW; XANTHIUM;

ADMINISTRATION, INHALATION; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHODILATOR AGENTS; HUMANS; INFLAMMATION; LEUKOTRIENE ANTAGONISTS; STEROIDS;

EID: 0035868962     PISSN: 00352640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. b-adrenergic bronchodilators
2. Aspects actuels des récepteurs β2-adrénergiques et des β2-stimulants dans l'asthme
3. Long-acting β2-adrenoceptor agonists: A new perspective in the treatment of asthma
4. β2-mimétiques de longue durée d'action dans l'asthme: Actualités
5. Theophylline and airway inflammation
6. Theophylline in asthma
7. Addition of intravenous aminophylline to β 2-agonists in adult with acute asthma (Cochrane Review)
8. A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma
9. Muscarinic receptors and control of airway smooth muscle
10. Leukotrienes, leukotriene antagonists and leukotriene synthesis inhibitors in asthma: An update. Part II: Clinical studies with leukotriene antagonists and leukotriene synthesis inhibitors in asthma
11. Inhaled glucocorticoids for asthma
12. Efficacy and safety of inhaled corticosteroids
13. Suppression and recovery of adrenal response after short-term high-dose glucocorticoid treatment
14. Added salmeterol versus higher dose corticosteroids in asthma patients
15. Effect of inhaled formoterol and budesonide on exacerbations of asthma
16. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial
17. Combined salmeterol 50 μg and fluticasone propionate 250 μg in the diskus device for the treatment of asthma
18. Salmeterol enhances the inhibitory activity of dexamethasone on allergen-induced blood mononuclear cell activation
19. Synergistic inhibition by β2-agonists and corticosteroids on tumor necrosis factor a-induced interleukin-8 release from cultured human airway smooth muscle cells
20. Ligand-independant activation of the glucocorticoid receptor by β2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells
21. Interactions between corticosteroids and b2 agonists
22. Leukotrienes, leukotriene antagonists and leukotriene synthesis inhibitors in asthma: An update. Part I: Synthesis, receptors and role of leukotrienes in asthma
23. Sodium cromoglycate and nedocromil sodium in the therapy of asthma, a critical comparison
24. A comparative study of the clinical efficacy of nedocromil sodium and placebo
25. Place des anti-allergiques dans le traitement de l'asthme
26. Comparative effects of long-acting β2-agonists, leukotriene receptor antagonists and α 5-lipoxygenase inhibitor on exercise-induced asthma